Back to search

Article

Efficacy and Safety of Remimazolam Mesylate in General Anesthesia Induction and Maintenance in Elderly Patients: A Single-Center, Randomized, Positive-Drug, Paralleled, Controlled Study

2022-08-02

Abstract excerpt

<h4>Objective: </h4> To evaluate the efficacy and safety of remimazolam mesylate for general anesthesia in elderly patients. Methods Patents aged 60 to 80 years who were scheduled to undergo surgery were randomized into three groups: Group A (remimazolam mesylate 6 mg/kg/h), Group B (remimazolam mesylate 12 mg/kg/h), or Group C (propofol 2.0-2.5 mg/kg). Primary efficacy indicators (success rate of anesthesia seda...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
328d72ea-63dd-5726-86f2-1c59a9620ebd
DOI
10.21203/rs.3.rs-1820076/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of Remimazolam Mesylate in General Anesthesia Induction and Maintenance in Elderly Patients: A Single-Center, Randomized, Positive-Drug, Paralleled, Controlled StudyDOI 10.21203/rs.3.rs-1820076/v1
Select a neighboring publication to make it the new centre.